c‐MYC, an oncogenic transcription factor, promotes the EMT process by regulating key markers, including downregulating E‐cadherin and upregulating N‐cadherin, while also interacting with multiple signaling pathways to enhance the invasive and metastatic potential of tumor cells [44, 46, 49]. The gene discussed is CDH1; the disease is neoplasm.